Fuling Zhou

InstitutionZhongnan Hospital of Wuhan University
AddressWuhan
Hubei
China
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 15 Covid-19 publications, with a maximum of 3 publications in June 2020 and July 2020
    All Publications
    Bar chart showing 75 publications over 16 distinct years, with a maximum of 15 publications in 2017
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Ji SQ, Zhang M, Zhang Y, Xia K, Chen Y, Chu Q, Wei YC, Zhou FL, Bu BT, Tu HL, Cao YY, Hu LY. Characteristics of immune and inflammatory responses among different age groups of pediatric patients with COVID-19 in China. World J Pediatr. 2021 Aug; 17(4):375-384. PMID: 34341947.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    2. Xu D, Zhou F, Sun W, Chen L, Lan L, Li H, Xiao F, Li Y, Kolachalama VB, Li Y, Wang X, Xu H. Relationship Between Serum Severe Acute Respiratory Syndrome Coronavirus 2 Nucleic Acid and Organ Damage in Coronavirus 2019 Patients: A Cohort Study. Clin Infect Dis. 2021 07 01; 73(1):68-75. PMID: 32720678.
      Citations: 18     Fields:    Translation:Humans
    3. Pang B, Li H, Liu Q, Wu P, Xia T, Zhang X, Le W, Li J, Lai L, Ou C, Ma J, Liu S, Zhou F, Wang X, Xie J, Zhang Q, Jiang M, Liu Y, Zeng Q. CT Quantification of COVID-19 Pneumonia at Admission Can Predict Progression to Critical Illness: A Retrospective Multicenter Cohort Study. Front Med (Lausanne). 2021; 8:689568. PMID: 34222293.
      Citations:    
    4. Shang Y, Liu T, Li J, Kaweme NM, Wang X, Zhou F. Impact of Treatment Regimens on Antibody Response to the SARS-CoV-2 Coronavirus. Front Immunol. 2021; 12:580147. PMID: 33936026.
      Citations:    Fields:    Translation:Humans
    5. Yu Y, Liu T, Shao L, Li X, He CK, Jamal M, Luo Y, Wang Y, Liu Y, Shang Y, Pan Y, Wang X, Zhou F. Novel biomarkers for the prediction of COVID-19 progression a retrospective, multi-center cohort study. Virulence. 2020 12; 11(1):1569-1581. PMID: 33172355.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    6. Zhou F, Li J, Lu M, Ma L, Pan Y, Liu X, Zhu X, Hu C, Wu S, Chen L, Wang Y, Wei Y, Li Y, Xu H, Wang X, Cai L. Tracing asymptomatic SARS-CoV-2 carriers among 3674 hospital staff:a cross-sectional survey. EClinicalMedicine. 2020 Sep; 26:100510. PMID: 32954232.
      Citations: 9     
    7. Shang Y, Liu T, Li J, Wang X, Zhou F. Factors affecting antibody response to SARS-CoV-2 in patients with severe COVID-19. J Med Virol. 2021 02; 93(2):612-614. PMID: 33289107.
      Citations: 4     Fields:    Translation:Humans
    8. Xiong B, Liu T, Luo P, Wei Y, Zhou Y, Liu M, Zhang Y, Wang H, Zhang X, Wang X, Zhou F. Prominent Hypercoagulability Associated With Inflammatory State Among Cancer Patients With SARS-CoV-2 Infection. Front Oncol. 2020; 10:1345. PMID: 32766161.
      Citations: 1     
    9. Wu Y, Huang X, Sun J, Xie T, Lei Y, Muhammad J, Li X, Zeng X, Zhou F, Qin H, Shao L, Zhang Q. Clinical Characteristics and Immune Injury Mechanisms in 71 Patients with COVID-19. mSphere. 2020 07 15; 5(4). PMID: 32669467.
      Citations: 13     Fields:    Translation:HumansCellsPHPublic Health
    10. Shang Y, Liu T, Wei Y, Li J, Shao L, Liu M, Zhang Y, Zhao Z, Xu H, Peng Z, Zhou F, Wang X. Scoring systems for predicting mortality for severe patients with COVID-19. EClinicalMedicine. 2020 Jul; 24:100426. PMID: 32766541.
      Citations: 40     
    11. Wang Y, Li J, Liu L, Li J, Liu X, He J, Wang C, Ye D, Wang X, Zhou F. Measures for preventing nosocomial infection with SARS-CoV-2 in hematology departments. Ann Hematol. 2020 08; 99(8):1933-1938. PMID: 32601797.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    12. Liu T, Zeng G, Tao H, Shi Y, Wang T, Liu T, Guo F, Zhou F, Wang X. Low prevalence of IgG antibodies to SARS-CoV-2 in cancer patients with COVID-19. Int J Cancer. 2020 12 01; 147(11):3267-3269. PMID: 32525566.
      Citations: 15     Fields:    Translation:HumansCellsPHPublic Health
    13. Liu T, Wu S, Zeng G, Zhou F, Li Y, Guo F, Wang X. Recurrent positive SARS-CoV-2: Immune certificate may not be valid. J Med Virol. 2020 11; 92(11):2384-2386. PMID: 32470172.
      Citations: 11     Fields:    Translation:Humans
    14. Shao L, Li X, Zhou Y, Yu Y, Liu Y, Liu M, Zhang R, Zhang H, Wang X, Zhou F. Novel Insights Into Illness Progression and Risk Profiles for Mortality in Non-survivors of COVID-19. Front Med (Lausanne). 2020; 7:246. PMID: 32574334.
      Citations: 9     
    15. Liu X, Li Z, Liu S, Sun J, Chen Z, Jiang M, Zhang Q, Wei Y, Wang X, Huang YY, Shi Y, Xu Y, Xian H, Bai F, Ou C, Xiong B, Lew AM, Cui J, Fang R, Huang H, Zhao J, Hong X, Zhang Y, Zhou F, Luo HB. Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19. Acta Pharm Sin B. 2020 Jul; 10(7):1205-1215. PMID: 32318327.
      Citations: 85     
    Zhou's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (212)
    Explore
    _
    Co-Authors (132)
    Explore
    _
    Similar People (60)
    Explore
    _